Flow: Deep vein thrombosis in patients with neo-coronary pneumonia.

The purpose of this study was to investigate the occurrence of deep vein thrombosis (DVT) in hospitalized patients with new coronary pneumonia, including its rate, risk factors, prognosis, and potential thrombosis prevention strategies.
included 143 patients with neo-crown pneumonia who were hospitalized at Wuhan Hospital from January 29 to February 29, 2020.
of the 143 patients with neo-coronary pneumonia (average age 63, 51.7% were men), 66 had lower limb DVT (46.1%: 23 near-end DVTs and 43 far-end DVTs).
patients with DVT were older, had lower oxygenation, had higher cardiomyopathy rates, and had poorer prognosis than those without DVT, including higher mortality (34.8% vs. 11.7%) and lower discharge rates (48.5% vs 77.9%).
multivariate analysis showed that in the queue, only CURB-65 (consciousness status, urea, breathing rate and blood pressure) scored 3-5 points (advantage must be 6.122; There is an association between P-0.031, Padua's predicted score of 4 points (4.016; P-0.04), D-D-D-polymer,1.0 μg/mL (5.818; P.lt;0.014), and DVT.
combined CURB-65 3-5 points, Padua predicted score of 4 points and D-D-D-D-polymer;1.0 μg/mL screening DVT sensitivity was 88.52%, with specificity of 61.43%.
Among subgroups of patients who received venous thrombosis prevention after Padua's predicted score of 4 points and 72 hours of hospitalization, the rate of DVT was 34.0% (18) and that of patients without preventive treatment was as high as 66.0% (35).
for patients with new coronary pneumonia treated in hospital, the risk of DVT is high and is associated with poor prognosis.
prevention of venous thrombosis had a protective effect on patients with Padua's predicted score of 4 points.
study suggests that COVID-19 may be an additional risk factor for DVT in hospitalized patients.
.